| Authors: |
Penas-Prado M; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland., Wu J; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Brat DJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Costello JF; Department of Neurological Surgery, University of California, San Francisco., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Washington DC., Cairncross JG; Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., van den Bent M; Neuro-Oncology Unit, Erasmus MC Cancer Center, Rotterdam, The Netherlands., Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Aboud O; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland.; Brain Tumor Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Burger P; Neuropathology Division, Johns Hopkins, Baltimore, Maryland., Chang SM; Department of Neurological Surgery, University of California, San Francisco., Cordova C; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland.; NYU School of Medicine, Laura and Isaac Perlmutter Cancer Center, New York, NY., Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts., Rowe LS; Radiation Oncology Branch/National Cancer Institute, Bethesda, Maryland., Taphoorn MJB; Leiden University Medical Center and Haaglanden Medical Center, The Hague, The Netherlands., Gilbert MR; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland., Armstrong TS; Neuro-Oncology Branch/National Cancer Institute, Bethesda, Maryland. |
